Nano Dimension
NNDM · NASDAQ
About NNDM
- Employees
- 468
- Headquarters
- Ness Ziona, Central(HaMerkaz)
- Listed
- Jan 1, 1977
- Sector
- Industrials
- Industry
- Machinery
- Website
- nano-di.com
NNDM key statistics
- Market cap
- 296.93M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 1.50M
- Volume
- 1.24M
- Open price
- $1.42
- High today
- $1.43
- Low today
- $1.39
- 52 Week high
- $2.32
- 52 Week low
- $1.19
Nano Dimension (NNDM) at a glance
Nano Dimension (NNDM) last traded at $1.40, with a market cap of 296.93M and a price-to-earnings ratio of 0.00.
Today the stock has traded between $1.39 and $1.43. The current price is 0.7% above the day's low and 2.1% below its high.
Volume so far is 1.24M shares, in line with the average of 1.50M shares a day.
Over the past year Nano Dimension has ranged from $1.19 to $2.32, and now sits 19% of the way up that range.
Nano Dimension met or beat analyst EPS estimates in 2 of the last 8 quarters. In Q1 FY26 it reported -$0.34 per share against an estimate of $0.00.
NNDM earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 2 of the last 8 quarters, by 60.6% on average.
- Q1 FY19: reported -$0.50 per share against an estimate of -$1.68
- Q2 FY20: reported -$0.27 per share against an estimate of -$0.0918
- Q4 FY20: reported -$0.02 per share against an estimate of -$0.0408
- Q4 FY22: reported -$0.34 per share against an estimate of $0.00
- Q1 FY24: reported -$0.15 per share against an estimate of $0.00
- Q2 FY25: reported -$0.01 per share against an estimate of $0.00
- Q3 FY25: reported -$0.09 per share against an estimate of $0.00
- Q1 FY26: reported -$0.34 per share against an estimate of $0.00
NNDM news
- Press releaseBusiness Wire
- Press releaseGlobe Newswire
Nano Dimension and Infinite Epigenetics Provide Additional Information Regarding Proposed Business Combination
- Press releaseBusiness Wire
Murchinson Criticizes the Nano Dimension Board of Directors' Decision to Pursue a Seemingly Deeply Flawed Transaction with Infinite Epigenetics
- Press releaseGlobe Newswire
Nano Dimension Signs Term Sheet with Infinite Epigenetics to Form a Publicly Traded, AI-Powered Preventive Health and Diagnostics Company
- Press releaseBusiness Wire
Murchinson Invites Fellow Nano Dimension Shareholders to Participate In a Survey: What Trendy Industry Is the Board, Under Chairman Bob Pons' Leadership, Planning to Chase Next?
- Caroline Ryan
Deal Dispatch: Jasper Therapeutics For Sale, RobinHood Completes $180 Million WonderFi Acquisition, Long John Silver's Franchisee To Liquidate
- Caroline Ryan
Deal Dispatch: Fertitta Entertainment Buys Caesars For $17.6 Billion, Arsenal Capital Buys Velcro Brands, Teaneck Surgical Center Bankruptcy
- Press releaseBusiness Wire
Murchinson Invites Fellow Nano Dimension Shareholders to an Investor Call to Discuss the Current State of the Company
Similar companies
Companies in the same industry as Nano Dimension
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- FRTTFort Technology$0.7121+32.63%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.